Invesco Biotechnology & Genome ETF
PBE
PBE
78 hedge funds and large institutions have $61.8M invested in Invesco Biotechnology & Genome ETF in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 30 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 30
Holders
78
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.06M | |
| 2 | +$767K | |
| 3 | +$414K | |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
+$262K |
| 5 |
Neuberger Berman Group
New York
|
+$223K |
Top Sellers
| 1 | -$7.15M | |
| 2 | -$796K | |
| 3 | -$668K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$441K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$392K |